PremiumThe FlyAddex Therapeutics regains rights to ADX71149 Legend Biotech Stock (LEGN) Up on Strong Sales and Bullish Analyst Outlook Johnson & Johnson price target raised to $164 from $162 at Raymond James PremiumRatingsJohnson & Johnson: Balancing Stability and Risks Amid Tariff Challenges Cautious Outlook on Johnson & Johnson’s Orthopedic Segment Amid Slowed Growth and Competitive Pressure Johnson & Johnson Stock: Fairly Valued with Neutral Outlook Amid Uncertain Growth Prospects PremiumEarning ReleasesJohnson & Johnson Earnings Report: Is it a Beat? JNJ Stock Slips as Investors Worry about the Impact of Tariffs Big banks report Q1 beats, China stops taking Boeing deliveries: Morning Buzz 
